Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-20T02:23:17.677Z Has data issue: false hasContentIssue false

Impact of a preconception counselling resource (DVD) on preconception folic acid intake in women with diabetes

Published online by Cambridge University Press:  24 September 2014

L. L. Hamill
Affiliation:
Centre for Public Health, Queen's University Belfast BT12 6BJ
D. R. McCance
Affiliation:
Regional Centre for Endocrinology and Diabetes, Belfast Health and Social Care Trust, Belfast BT12 6BA
M. Deery
Affiliation:
Centre for Public Health, Queen's University Belfast BT12 6BJ
C. C. Patterson
Affiliation:
Centre for Public Health, Queen's University Belfast BT12 6BJ
F. A. Alderdice
Affiliation:
School of Nursing and Midwifery, Queen's University Belfast BT9 7BL
M. Spence
Affiliation:
School of Biological Sciences, Queen's University Belfast BT9 7BL
A. Gough
Affiliation:
Centre for Public Health, Queen's University Belfast BT12 6BJ
R. Harper
Affiliation:
Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, Belfast BT16 1RH
V. A. Holmes
Affiliation:
Centre for Public Health, Queen's University Belfast BT12 6BJ
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2014 

Women with diabetes face increased risk of pregnancy complications and adverse outcomes compared to the background population, with a fivefold increased risk of stillbirth and twofold increased risk of congenital malformation( 1 ). It is therefore recommended that women with diabetes who are planning pregnancy take a high dose (5 mg)of folic acid preconception and until at least week 12 of pregnancy. An innovative multimedia educational DVD resource was developed by the Women with Diabetes project team, to raise awareness of the importance of planning for pregnancy( Reference Holmes, Spence and McCance 2 ). The DVD was embedded into routine care in Northern Ireland in 2010 (4,710 DVDs distributed via diabetes care teams and GP practices) and a regional audit was carried out before (pre) and after (post) integration of the DVD. The aim of this study was to compare preconception folic acid use, and uptake of the 5 mg dose before and after the DVD was made available to women.

Women who delivered/expected to deliver between 1st September 2009 and 31st August 2010 were included in the pre DVD audit (n 114; type 1n88; type 2 n26) while women who delivered/expected to deliver between 1st February 2012 and 31st January 2013 were included in the post DVD audit (n 135: type 1 n95; type 2 n40). A secondary, per protocol analysis was also carried out i.e. pre DVD vs watched DVD (n 58: type 1 n 50; type 2 n8). Data comparisons between groups were made using Chi-square tests. Logistic regressions were performed, adjusting for diabetes type, diabetes duration, parity, area deprivation, age, and booking hospital.

Post DVD women were more likely to have planned their pregnancy and to have taken folic acid preconception when compared to the pre DVD group, although this did not reach statistical significance. However, women who watched the DVD were significantly more likely to have planned their pregnancy (88% vs 59%, P < 0·01), taken folic acid preconception (81% vs 42%, P < 0·01) and, although not significant, they were also more likely to have taken a 5 mg dose (93% vs 75%, P = 0·06) when compared to women pre DVD.

*Pre DVD vs Post DVD, +Pre DVD vs watched DVD.

The findings presented here suggest that implementation of a preconception counselling resource into routine care played a positive role in relation to folic acid uptake for those women who watched the DVD. Preconception counselling for all women with diabetes is essential to signpost women to the appropriate pre-pregnancy care services. An ongoing knowledge transfer process will be instrumental in maximising the impact of this resource3 to raise awareness of the importance of planning for pregnancy among women with diabetes.

References

1.CEMACH, 2005.Google Scholar
2. Holmes, VA, Spence, M, McCance, DR et al. (2012) Diabet Med 29(7), 950956.Google Scholar